(a Chinese export company) NDC: 84778-108 Marketing status: Export only Marketing start date: October 29, 2025 Not manufactured by Eli Lilly Not FDA-approved for use in the United States The DailyMed entry ranks second organically for "retatrutide pen" searches, which is why so many users encounter it and assume it represents a legitimate commercial product
However, this is something your doctor should monitor, especially if you have a history of heart disease or stroke
Week 5 increases to 0.5 mg weekly for four weeks, then advances to 1.0 mg weekly in week 9, followed by 1.7 mg weekly beginning week 13
Yabe D, Seino Y, Seino Y (2018) Incretin concept revised: the origin of the insulinotropic function of glucagon-like peptide-1: the gut, the islets or both
Research into GLP-1s is developing, with new information on their efficacy, side effects, and safety being published regularly